AMSBIO Announces US Office

AMSBIO has announced, as of 31st March 2011, the opening of a new North American subsidiary company - AMSBIO LLC**.

After successfully selling innovative life science technologies, biotools and services directly to North American researchers, the new office will be a fully integrated entity supporting the AMSBIO product line with a dedicated sales and service facility in Orange County, California.

Commenting on this strategic move, Alex Sim (President, AMSBIO) said 'The US is the single largest market for our stem cell and regenerative medicine, lentivirus as well as tissue derived products and our North American customer base has been growing strongly over recent years'.  He added 'In addition to providing local service and support for our US customers the new facilities will be able to offer next day delivery from a comprehensive inventory of popular products.

AMSBIO will be exhibiting in April at the American Association for Cancer Research meeting in Orlando, and in May 2011 at the American Association of Immunologists Annual Meeting in San Francisco.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized as a leading international provider of unique & innovative products & custom services for life sciences research. The AMSBIO range includes over 43,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & and includes Zymolyase, RNA Stat-60 and Alvetex.  Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, electrophoresis, glycobiology, posttranslational modification & stem cell biology.

For further information visit http://www.amsbio.com/ or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com.